Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TNKS | O95271 | 1/20 | 0.32 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24700746 | 0.91 | TNKS (0.33) | TNKSTNKS2LMNAPOLBMAPT | |
| SCHEMBL19161619 | 0.77 | TNKS (0.47) | TNKSTNKS2LMNAMAPTHTT | |
| SCHEMBL24474775 | 0.76 | — | — | |
| SCHEMBL23473641 | 0.76 | TNKS (0.36) | TNKSTNKS2MAPT | |
| SCHEMBL24474776 | 0.76 | MAPT (0.36) | LMNAPOLBMAPTTSHRHTT | |
| SCHEMBL19162670 | 0.75 | TNKS (0.46) | TNKSTNKS2LMNAMAPTHTT | |
| SCHEMBL24701231 | 0.74 | MAPT (0.37) | LMNAPOLBMAPTTSHRHTT | |
| SCHEMBL19162671 | 0.74 | MAPT (0.47) | LMNAPOLBMAPTTSHRHTT | |
| SCHEMBL18017932 | 0.73 | MAPT (0.41) | LMNAPOLBMAPTTSHRHTT | |
| SCHEMBL23473704 | 0.72 | TNKS (0.42) | TNKSTNKS2LMNAMAPTHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220173330-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) | 2022-06-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220173330-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | LEF1, ODC1, OR10J3 | TNKS 2226/4885TNKS2 3228/4885LMNA 3879/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.